High Net Worth Advisory Group LLC Astrazeneca PLC Transaction History

High Net Worth Advisory Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $124,032 - $161,166	-2,288 Reduced 63.52%	1,314 $89,000
Q3 2022 Oct 24, 2022	BUY	$53.02 - $135.75 $424 - $1,086	8 Added 0.22%	3,602 $198,000
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $118,520 - $142,280	2,000 Added 125.47%	3,594 $237,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $55 - $67	1 Added 0.06%	1,594 $106,000
Q4 2021 Apr 27, 2022	BUY	$54.02 - $63.83 $86,053 - $101,681	1,593 New	1,593 $91,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.